Published May 7, 2024

Ep 139 Supplements: “This statement has not been evaluated by the FDA”

Exploring the booming dietary supplement industry, this episode delves into the regulatory gaps, consumer safety concerns, and the pandemic-driven surge in product consumption, highlighting the complex dynamics between industry freedom and the need for stringent oversight.

Episode Highlights

Topics covered

Episode Highlights

Related Episodes

Ep 113 Vitamin D: The D stands for drama
Answers 383 questions
Ep 157 Retinoids Part 2: …how it’s going
Answers 383 questions
Ep 19 Scurvy: Thanks a lot, evolution.
Answers 383 questions
Ep 156 Retinoids Part 1: How it started…
Answers 383 questions
Ep 27 Vaccines Part 2: Have you thanked your immune system lately?
Answers 383 questions
Re-Release: Ep 27 Vaccines Part 2: Have you thanked your immune system lately?
Answers 383 questions
Special Episode: Deborah Blum & The Poison Squad
Answers 383 questions
Ep 149 Poison Control Part 2: Call me maybe
Answers 383 questions
COVID-19 Chapter 13: Vaccines, Take 2
Answers 383 questions
Ep 26 Vaccines part 1: Let's hear it for Maurice
Answers 383 questions
Ep 59 Thalidomide: Justice Delayed, Justice Denied
Answers 383 questions
Ep 152 Hemochromatosis: Ironing out the details
Answers 383 questions
Re-Release: Ep 26 Vaccines Part 1: Let's hear it for Maurice
Answers 383 questions
Ep 75 Mercury: The cost of progress
Answers 383 questions
Ep 89 Hepatitis B: Hepatiti, Take 2
Answers 383 questions

Dexa/This Podcast Will Kill You

Ep 139 Supplements: “This statement has not been evaluated by the FDA”

Topics covered

Popular Clips

Defining Dietary Supplements

Supplement Regulation Issues

Supplement Regulation History

Supplementation Insights

Dark Side of Supplements

Understanding Supplements

Wellness Industry Insights

Supplement Regulation Shift

Supplement Surge

Regulatory Evolution

Supplement Regulation Insights

Trust in Medicine

Regulatory Failures Unveiled

Regulation Revolution

Vitamin Regulation Chaos

Episode Highlights

Regulation Challenges

Health and Safety Concerns

Supplement Industry Growth

Related Episodes

Ep 113 Vitamin D: The D stands for drama

Ep 157 Retinoids Part 2: …how it’s going

Ep 19 Scurvy: Thanks a lot, evolution.

Ep 156 Retinoids Part 1: How it started…

Ep 27 Vaccines Part 2: Have you thanked your immune system lately?

Re-Release: Ep 27 Vaccines Part 2: Have you thanked your immune system lately?

Special Episode: Deborah Blum & The Poison Squad

Ep 149 Poison Control Part 2: Call me maybe

COVID-19 Chapter 13: Vaccines, Take 2

Ep 26 Vaccines part 1: Let's hear it for Maurice

Ep 59 Thalidomide: Justice Delayed, Justice Denied

Ep 152 Hemochromatosis: Ironing out the details

Re-Release: Ep 26 Vaccines Part 1: Let's hear it for Maurice

Ep 75 Mercury: The cost of progress

Ep 89 Hepatitis B: Hepatiti, Take 2

Ep 139 Supplements: “This statement has not been evaluated by the FDA”

Topics covered

Popular Clips

Episode Highlights

Regulation ChallengesThe historical and current regulatory landscape of dietary supplements reveals a shift from consumer protection to industry freedom. This change has led to significant challenges in oversight and enforcement, impacting consumer safety and product reliability.

Regulation Challenges

Health and Safety ConcernsThe podcast explores the significant risks and regulatory challenges associated with dietary supplements. Erin Updyke and Erin Welsh discuss the prevalence of adverse events and the lack of stringent safety regulations.

Health and Safety Concerns

Supplement Industry Growth

Related Episodes